Northwest Biotherapeutics, Inc. (NWBO)
0.1993
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Northwest Biotherapeutics EPS Diluted (Quarterly) : 0.0008 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.292 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.388M |
| Revenue (Quarterly) | 0.672M |
| Total Expenses (Quarterly) | -0.716M |
| Enterprise Value | 403.03M |
| Gross Profit Margin (Quarterly) | -19.20% |
| Earnings Yield | -21.53% |
| Normalized Earnings Yield | -21.98 |